Phaarmasia Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Net Loss of Phaarmasia reported to Rs 0.70 crore in the quarter ended March 2026 as against net loss of Rs 0.53 crore during the previous quarter ended March 2025. Sales rose 42.36% to Rs 7.73 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 17.57 crore in the year ended March 2026 as against net loss of Rs 1.59 crore during the previous year ended March 2025. Sales rose 93.72% to Rs 47.21 crore in the year ended March 2026 as against Rs 24.37 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Phaarmasia will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Phaarmasia reported to Rs 16.27 crore in the quarter ended December 2025 as against net loss of Rs 0.70 crore during the previous quarter ended December 2024. Sales rose 240.04% to Rs 16.05 crore in the quarter ended December 2025 as against Rs 4.72 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News

Phaarmasia will hold a meeting of the Board of Directors of the Company on 6 February 2026.

Powered by Capital Market - Live News